A method for inferring regional origins of neurodegeneration

Alzheimer's disease, the most common form of dementia, is characterized by the emergence and spread of senile plaques and neurofibrillary tangles, causing widespread neurodegeneration. Though the progression of Alzheimer's disease is considered to be stereotyped, the significant variability within clinical populations obscures this interpretation on the individual level. Of particular clinical importance is understanding where exactly pathology, e.g. tau, emerges in each patient and how the incipient atrophy pattern relates to future spread of disease. Here we demonstrate a newly developed graph theoretical method of inferring prior disease states in patients with Alzheimer's disease and mild cognitive impairment using an established network diffusion model and an L1-penalized optimization algorithm. Although the 'seeds' of origin using our inference method successfully reproduce known trends in Alzheimer's disease staging on a population level, we observed that the high degree of heterogeneity between patients at baseline is also reflected in their seeds. Additionally, the individualized seeds are significantly more predictive of future atrophy than a single seed placed at the hippocampus. Our findings illustrate that understanding where disease originates in individuals is critical to determining how it progresses and that our method allows us to infer early stages of disease from atrophy patterns observed at diagnosis.

[1]  H. Braak,et al.  Evolution of Alzheimer’s disease-related cytoskeletal changes in the basal nucleus of Meynert , 2000, Acta Neuropathologica.

[2]  Ninon Burgos,et al.  New advances in the Clinica software platform for clinical neuroimaging studies , 2019 .

[3]  Zeshan Ahmed,et al.  A novel in vivo model of tau propagation with rapid and progressive neurofibrillary tangle pathology: the pattern of spread is determined by connectivity, not proximity , 2014, Acta Neuropathologica.

[4]  Efstathios D. Gennatas,et al.  Predicting Regional Neurodegeneration from the Healthy Brain Functional Connectome , 2012, Neuron.

[5]  Kiralee M. Hayashi,et al.  Dynamics of Gray Matter Loss in Alzheimer's Disease , 2003, The Journal of Neuroscience.

[6]  G Forster,et al.  Hippocampal tau pathology is related to neuroanatomical connections: an ageing population-based study. , 2009, Brain : a journal of neurology.

[7]  John C. Morris,et al.  AV-1451 PET imaging of tau pathology in preclinical Alzheimer disease: Defining a summary measure , 2017, NeuroImage.

[8]  D. Na,et al.  Tau positron emission tomography using [18F]THK5351 and cerebral glucose hypometabolism in Alzheimer's disease , 2017, Neurobiology of Aging.

[9]  Philip S. Insel,et al.  Effects of Baseline CSF α-Synuclein on Regional Brain Atrophy Rates in Healthy Elders, Mild Cognitive Impairment and Alzheimer’s Disease , 2013, PloS one.

[10]  C. Jack,et al.  Neuroimaging correlates of pathologically defined subtypes of Alzheimer's disease: a case-control study , 2012, The Lancet Neurology.

[11]  M. Diamond,et al.  Prion-like mechanisms in neurodegenerative diseases , 2010, Nature Reviews Neuroscience.

[12]  J. Baron,et al.  In Vivo Mapping of Gray Matter Loss with Voxel-Based Morphometry in Mild Alzheimer's Disease , 2001, NeuroImage.

[13]  Stefan Klöppel,et al.  Gray matter atrophy pattern in elderly with subjective memory impairment , 2014, Alzheimer's & Dementia.

[14]  A. Raj,et al.  Connectivity, not region-intrinsic properties, predicts regional vulnerability to progressive tau pathology in mouse models of disease , 2017, Acta Neuropathologica Communications.

[15]  S. A. Hussaini,et al.  Neuronal activity enhances tau propagation and tau pathology in vivo , 2016, Nature Neuroscience.

[16]  Bruce Fischl,et al.  Within-subject template estimation for unbiased longitudinal image analysis , 2012, NeuroImage.

[17]  J. Trojanowski,et al.  Integration and relative value of biomarkers for prediction of MCI to AD progression: Spatial patterns of brain atrophy, cognitive scores, APOE genotype and CSF biomarkers , 2013, NeuroImage: Clinical.

[18]  Anders M. Dale,et al.  Sequence-independent segmentation of magnetic resonance images , 2004, NeuroImage.

[19]  Corinne E. Fischer,et al.  Gray matter atrophy in patients with mild cognitive impairment/Alzheimer's disease over the course of developing delusions , 2016, International journal of geriatric psychiatry.

[20]  Norbert Schuff,et al.  Robust Identification of Alzheimer’s Disease subtypes based on cortical atrophy patterns , 2017 .

[21]  Bill Seeley,et al.  Neurodegenerative diseases target large-scale human brain networks , 2010, Alzheimer's & Dementia.

[22]  Martin Beibel,et al.  Transmission and spreading of tauopathy in transgenic mouse brain , 2009, Nature Cell Biology.

[23]  Daniel C. Alexander,et al.  Camino: Open-Source Diffusion-MRI Reconstruction and Processing , 2006 .

[24]  H. Braak,et al.  Phases of Aβ-deposition in the human brain and its relevance for the development of AD , 2002, Neurology.

[25]  J. Trojanowski,et al.  Tau pathology spread in PS19 tau transgenic mice following locus coeruleus (LC) injections of synthetic tau fibrils is determined by the LC’s afferent and efferent connections , 2015, Acta Neuropathologica.

[26]  H. Braak,et al.  The evolution of Alzheimer's disease‐related cytoskeletal pathology in the human raphe nuclei , 2000, Neuropathology and applied neurobiology.

[27]  J. Trojanowski,et al.  Heterogeneity of neuroanatomical patterns in prodromal Alzheimer’s disease: links to cognition, progression and biomarkers , 2016, Brain : a journal of neurology.

[28]  Alan C. Evans,et al.  Epidemic Spreading Model to Characterize Misfolded Proteins Propagation in Aging and Associated Neurodegenerative Disorders , 2014, PLoS Comput. Biol..

[29]  Sang Won Seo,et al.  Anatomical heterogeneity of Alzheimer disease , 2014, Neurology.

[30]  Murray Grossman,et al.  Signature tau neuropathology in gray and white matter of corticobasal degeneration. , 2002, The American journal of pathology.

[31]  Michael Weiner,et al.  Network Diffusion Model of Progression Predicts Longitudinal Patterns of Atrophy and Metabolism in Alzheimer's Disease. , 2015, Cell reports.

[32]  Paul M. Thompson,et al.  Localizing Sources of Brain Disease Progression with Network Diffusion Model , 2016, IEEE Journal of Selected Topics in Signal Processing.

[33]  R. Petersen,et al.  Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics: a retrospective study , 2011, The Lancet Neurology.

[34]  Mark W. Woolrich,et al.  FSL , 2012, NeuroImage.

[35]  J. Schott,et al.  Selective vulnerability in neurodegeneration: insights from clinical variants of Alzheimer's disease , 2016, Journal of Neurology, Neurosurgery & Psychiatry.

[36]  M. Weiner,et al.  A Network Diffusion Model of Disease Progression in Dementia , 2012, Neuron.

[37]  Kiralee M. Hayashi,et al.  Three-dimensional gray matter atrophy mapping in mild cognitive impairment and mild Alzheimer disease. , 2007, Archives of neurology.

[38]  R. Mayeux,et al.  Memory performance is related to amyloid and tau pathology in the hippocampus , 2009, Journal of Neurology, Neurosurgery, and Psychiatry.

[39]  Alan C. Evans,et al.  Multifactorial causal model of brain (dis)organization and therapeutic intervention: Application to Alzheimer’s disease , 2017, NeuroImage.

[40]  Keith A. Johnson,et al.  Association of In Vivo [18F]AV-1451 Tau PET Imaging Results With Cortical Atrophy and Symptoms in Typical and Atypical Alzheimer Disease , 2017, JAMA neurology.

[41]  K. Jellinger,et al.  The relationship between subcortical tau pathology and Alzheimer's disease. , 2012, Biochemical Society transactions.

[42]  K. Jellinger,et al.  Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature , 2012, Journal of neuropathology and experimental neurology.

[43]  Bradley T. Hyman,et al.  Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease , 1992, Neurology.

[44]  H. Braak,et al.  Evolution of the neuropathology of Alzheimer's disease , 1996, Acta neurologica Scandinavica. Supplementum.

[45]  Mathias Jucker,et al.  Self-propagation of pathogenic protein aggregates in neurodegenerative diseases , 2013, Nature.

[46]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.